Search research articles
Contact Us
Filters
Showing results (261-270 of 479) with videos related to
Page
of 48
Sort By:
Blood
|
June 2, 2005
The mutational spectrum of PTPN11 in juvenile myelomonocytic leukemia and Noonan syndrome/myeloproliferative disease
Christian P Kratz, Charlotte M Niemeyer, Robert P Castleberry, et al.
SLAS Discovery : Advancing Life Sciences R & D
|
May 11, 2018
High-Throughput Flow Cytometry Identifies Small-Molecule Inhibitors for Drug Repurposing in T-ALL
Dominique R Perez, Christian K Nickl, Anna Waller, et al.
International Journal of Cancer
|
August 4, 2015
Prospective, longitudinal assessment of quality of life in children from diagnosis to 3 months off treatment for standard risk acute lymphoblastic leukemia: Results of Children's Oncology Group study AALL0331
Hannah-Rose Mitchell, Xiaomin Lu, Regina M Myers, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 19, 2017
Reply to I.J. Cohen
Kristina K Hardy, Leanne M Embry, John A Kairalla, et al.
Leukemia
|
September 13, 2019
Fusion driven JMML: a novel CCDC88C-FLT3 fusion responsive to sorafenib identified by RNA sequencing
Alexander K Chao, Julia A Meyer, Alex G Lee, et al.
Blood
|
December 30, 2017
Measurable residual disease detection by high-throughput sequencing improves risk stratification for pediatric B-ALL
Brent Wood, David Wu, Beryl Crossley, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 24, 2017
Impact of Initial CSF Findings on Outcome Among Patients With National Cancer Institute Standard- and High-Risk B-Cell Acute Lymphoblastic Leukemia: A Report From the Children's Oncology Group
Naomi Winick, Meenakshi Devidas, Si Chen, et al.
Science (New York, N.Y.)
|
November 15, 2014
Oncogene regulation. An oncogenic super-enhancer formed through somatic mutation of a noncoding intergenic element
Marc R Mansour, Brian J Abraham, Lars Anders, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 1, 2007
Favorable outcome for adolescents with acute lymphoblastic leukemia treated on Dana-Farber Cancer Institute Acute Lymphoblastic Leukemia Consortium Protocols
Elly Barry, Daniel J DeAngelo, Donna Neuberg, et al.
Leukemia
|
April 12, 2022
JAK3 mutations and mitochondrial apoptosis resistance in T-cell acute lymphoblastic leukemia
Kimberly Bodaar, Natsuko Yamagata, Anais Barthe, et al.
Page
of 48
Search research articles
Search
Showing results (261-270 of 479) with videos related to
Sort By:
Page
of 48
Blood
|
June 2, 2005
The mutational spectrum of PTPN11 in juvenile myelomonocytic leukemia and Noonan syndrome/myeloproliferative disease
Christian P Kratz, Charlotte M Niemeyer, Robert P Castleberry, et al.
SLAS Discovery : Advancing Life Sciences R & D
|
May 11, 2018
High-Throughput Flow Cytometry Identifies Small-Molecule Inhibitors for Drug Repurposing in T-ALL
Dominique R Perez, Christian K Nickl, Anna Waller, et al.
International Journal of Cancer
|
August 4, 2015
Prospective, longitudinal assessment of quality of life in children from diagnosis to 3 months off treatment for standard risk acute lymphoblastic leukemia: Results of Children's Oncology Group study AALL0331
Hannah-Rose Mitchell, Xiaomin Lu, Regina M Myers, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 19, 2017
Reply to I.J. Cohen
Kristina K Hardy, Leanne M Embry, John A Kairalla, et al.
Leukemia
|
September 13, 2019
Fusion driven JMML: a novel CCDC88C-FLT3 fusion responsive to sorafenib identified by RNA sequencing
Alexander K Chao, Julia A Meyer, Alex G Lee, et al.
Blood
|
December 30, 2017
Measurable residual disease detection by high-throughput sequencing improves risk stratification for pediatric B-ALL
Brent Wood, David Wu, Beryl Crossley, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 24, 2017
Impact of Initial CSF Findings on Outcome Among Patients With National Cancer Institute Standard- and High-Risk B-Cell Acute Lymphoblastic Leukemia: A Report From the Children's Oncology Group
Naomi Winick, Meenakshi Devidas, Si Chen, et al.
Science (New York, N.Y.)
|
November 15, 2014
Oncogene regulation. An oncogenic super-enhancer formed through somatic mutation of a noncoding intergenic element
Marc R Mansour, Brian J Abraham, Lars Anders, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 1, 2007
Favorable outcome for adolescents with acute lymphoblastic leukemia treated on Dana-Farber Cancer Institute Acute Lymphoblastic Leukemia Consortium Protocols
Elly Barry, Daniel J DeAngelo, Donna Neuberg, et al.
Leukemia
|
April 12, 2022
JAK3 mutations and mitochondrial apoptosis resistance in T-cell acute lymphoblastic leukemia
Kimberly Bodaar, Natsuko Yamagata, Anais Barthe, et al.
Page
of 48